Exec. Director, Therapeutic Area Strategy, Cardiovascular

Your responsibilities include, but not limited to:  

• Develop Strategy for a Cardio Renal or Metabolic portfolio pillar and contribute to overall TA strategy.
• Define and drive mid-and-long term portfolio strategy, goals, strategic objectives and leadership aspiration within TA and DAs in collaboration with other functions within Strategy & Growth (S&G), and across US and International commercial, Biomedical Research, and Development units.
• Support the Therapeutic Area Leadership team (TAL) as the Enterprise strategic body that owns the TA Strategy and reviews all programs at Toll Gate transitions (from drug candidate to SDP).
• Lead strategy revisions and updates and orchestrate stakeholder alignment as needed, e.g., due to internal or external market events.
• Identify potential pipeline gaps and make recommendations to address with other S&G functions, US, International, Biomedical Research, and Development.
• Commercial lead on external evaluations for BD&L and acquisitions, inception to deal close.  Developing evaluations (across all phase products) based a thorough understanding of the TA, insights developed and tested externally using secondary analytics, PMR and CI. 
• Commercial lead on the early phase project teams (from drug candidate to Phase 3). Responsible for p3 programs transition to US and International Markets.
• Responsible for forecast and other commercial models’ development and alignment with key markets.
• Collaborate closely with key stakeholders (e.g., US, International, Biomedical Research, Development, and engage other functions such as Value & Access and US Market Access) to facilitate port-folio decision making in the context of our goal of becoming a top 5 Pharma player in the US while maintaining our international leadership.

What you’ll bring to the role:

• Advanced degree (PhD, MD cardiologist or internal medicine preferred) or equivalent experience in life science/healthcare; MBA.
• Significant experience gained in Pharma Industry with a strong Scientific or medical background. Extensive US market experience
• Significant BD&L and or M&A deal and evaluation experience (agile in assimilating technical and medical data, financial modelling (forecasting, P&L), conducting, commissioning, analyzing primary and secondary research)
• Demonstrated Consulting experience & C-suite presentation skills, written and oral. Proficiency in English required. (spoken and written). Effective and persuasive communicator with strong presentation, communication (both written and verbal), influencing and negotiation skills.
• Demonstrated Therapeutic Area (TA) knowledge and experience in Cardio Renal or Metabolic (or track record to acquire required TA expertise effectively and rapidly). Experience of strategy development and asset shaping early in lifecycle.
• Highly agile having the capacity to manage several strategic Disease Areas (Das) within a TA and multiple programs internal and external.
• Highly analytical with the ability to lead and thrive in high challenging environment.
• Travel: ability to travel domestically and internationally, to be determined based on business needs  

The pay range for this position at commencement of employment is expected to be between $233,600 to $350,400 per year; however, while salary ranges are effective from 1/1/24 through 12/31/24, fluctuations in the job market may necessitate adjustments to pay ranges during this period.  Further, final pay determinations will depend on various factors, including, but not limited to geographical location, experience level, knowledge, skills, and abilities. The total compensation package for this position may also include other elements, including a sign-on bonus, restricted stock units, and discretionary awards in addition to a full range of medical, financial, and/or other benefits (including 401(k) eligibility and various paid time off benefits, such as vacation, sick time, and parental leave), dependent on the position offered. Details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.

Read our handbook to learn about all the ways we’ll help you thrive personally and professionally: novartis-life-handbook.pdf

Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.